UK markets open in 2 hours 37 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
166.61+2.60 (+1.59%)
At close: 04:00PM EDT
166.25 -0.36 (-0.22%)
After hours: 07:58PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
5,083,000
6,754,000
18,875,000
17,736,000
274,000
Cost of revenue
3,997,000
4,693,000
5,416,000
2,617,000
8,000
Gross profit
1,086,000
2,061,000
13,459,000
15,119,000
266,000
Operating expenses
Research development
4,777,000
4,845,000
3,295,000
1,991,000
1,370,000
Selling general and administrative
1,518,000
1,549,000
1,132,000
567,000
188,000
Total operating expenses
6,225,000
6,300,000
4,039,000
1,823,000
1,029,000
Operating income or loss
-5,139,000
-4,239,000
9,420,000
13,296,000
-763,000
Interest expense
35,000
38,000
29,000
18,000
9,886
Total other income/expenses net
-60,000
-86,000
-16,000
-29,000
-6,000
Income before tax
-4,802,000
-3,942,000
9,575,000
13,285,000
-744,000
Income tax expense
1,166,000
772,000
1,213,000
1,083,000
3,000
Income from continuing operations
-5,968,000
-4,714,000
8,362,000
12,202,000
-747,000
Net income
-5,968,000
-4,714,000
8,362,000
12,202,000
-747,000
Net income available to common shareholders
-5,968,000
-4,714,000
8,362,000
12,202,000
-747,000
Basic EPS
-9.04
-12.33
21.26
30.31
-1.96
Diluted EPS
-9.23
-12.33
20.12
28.29
-1.96
Basic average shares
383,500
382,000
394,000
403,000
381,333
Diluted average shares
388,250
382,000
416,000
431,000
381,333